NEWS 10 FEED & ADDITIVE MAGAZINE June 2024 Germany-based pet food brand Dr. Clauder’s joined forces with protein pioneer Calysta to launch the world’s first dog treats made with FeedKind® Pet protein, a revolutionary new pet food ingredient. The air-dried treats from Dr. Clauder's were presented at the world’s leading pet trade fair, Interzoo. The product contains Calysta’s nutritionally rich protein produced by natural fermentation. According to the companies, its production by natural fermentation makes this protein an excellent nonGMO ingredient that meets market demands for nutritional quality, taste and health for pets. After its debut at Interzoo, the Dr. Clauder Trainee snack cultivated protein treat featuring FeedKind Pet, will be made available for sale in Europe. Calysta explains that FeedKind Pet protein is a fermented ingredient that is nutrient dense, has a complete amino acid profile for dogs, and has postbiotic properties that help maintain a healthy gut in animals. Additionally, FeedKind Pet is a vegan protein source. “Dog owners have high expectations for their pet’s food and are increasingly conscious about the source, quality, and safety of the ingredients used,” said Herman Sloot, vice president commercial development at Calysta. “For the first time, Europe’s pet food sector has the option to choose a high-quality source of protein that is nutritious and kind to the environment. Calysta is now producing at significant scale, and FeedKind Pet is approved for use in pet foods in the EU. We are excited Dr. Clauder’s is introducing a snack featuring FeedKind Pet protein as we set a new standard for dog treats – one that prioritises both taste and health, while looking after our planet,” Sloot added. Read more>> Veramaris announced that it marked a milestone by reaching record production volumes of 50% in 2023, contributing to the supply of alternative sources of Omega-3 EPA & DHA for aquafeed. The company added that it has been at the forefront of addressing the market's growing need for sustainable Omega-3 EPA & DHA, which has risen in parallel with the global trend towards greater demand for aquaculture and healthy seafood. "2023 marks a pivotal year for Veramaris, as we not only achieved a record increase in production volumes but also solidified our market position. We are now poised to scale up sustainably, streamlining our production processes and forging new partnerships," said Gertjan de Koning, CEO of Veramaris. As set out in the company’s new sustainable development report, this significant growth in output was achieved with only a marginal increase in greenhouse gas emissions. Veramaris reported only a 3% rise in total greenhouse gas emissions, demonstrating its progress in decarbonizing its operations. This commitment to sustainability is further evidenced by the recent registration of a 27% lower product carbon footprint, reflecting the company's ongoing efforts across multiple initiatives to simultaneously decarbonize and improve the efficiency of its operations, according to Veramaris. Read more>> Dr. Clauder’s and Calysta unveil fermented protein dog treat Veramaris increases Omega-3 EPA & DHA production
RkJQdWJsaXNoZXIy MTUxNjkxNQ==